Brocacef

Brocacef is owned by Phoenix India. Phoenix India has a direct presence in 6 countries.

Phoenix India has 5 subsidiaries including Amedis-UE, Brocacef and Comifar.

They are in:

• Pharmaceuticals67%
• Real Estate17%
• Other17%

View the org chart displaying its 3 main executives

Most searched biographies at Brocacef

• Peter de Jong, Chief Executive Officer
• Gerard Mulder, Group Manager wholesale
• Bart Tolhuisen, Chief Financial Officer and Group Director Finance

Create your alert
to follow the executive moves at Brocacef.

Phoenix India has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Brocacef

Social media about Brocacef

• Brocacef on Wikipedia, Google News & Yahoo Finance
• Brocacef on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter de Jong

Call Brocacef at +31 30...

View the org chart

Register to receive your alert

Report an error